CADASIL Clinical Trial
— MACOUPLING-CADOfficial title:
Etude Comparative en Imagerie Par résonnance magnétique et Par Enregistrement électroencéphalographique du Couplage Neurovasculaire Dans l'Angiopathie Cadasil
| Verified date | August 2021 |
| Source | Institut National de la Santé Et de la Recherche Médicale, France |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The aim of this study is to investigate using fMRI methods, EEG and dedicated mathematical models, the potential alterations of neurovascular coupling in CADASIL.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | October 24, 2016 |
| Est. primary completion date | October 24, 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 60 Years |
| Eligibility | Inclusion Criteria: - CADASIL group: typical NOTCH3 mutation, age less than 60 years, rankin score at 0-1, active social insurance Exclusion Criteria: - MRI contra-indications and use of any treatment known to interfere with neurovascular coupling, pregnancy, lack of informed consent |
| Country | Name | City | State |
|---|---|---|---|
| France | CENIR, Hopital Pitié Salpetriere | Paris |
| Lead Sponsor | Collaborator |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | model-derived parameters of neurovascular coupling | one time point |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
| Recruiting |
NCT05755997 -
CERebrolysin In CADASIL
|
Phase 2 | |
| Recruiting |
NCT06148051 -
AusCADASIL: An Australian Cohort of CADASIL
|
||
| Recruiting |
NCT04310098 -
CADASIL Registry Study
|
||
| Completed |
NCT01114815 -
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
|
N/A | |
| Recruiting |
NCT05677880 -
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
|
||
| Recruiting |
NCT02795052 -
Neurologic Stem Cell Treatment Study
|
N/A | |
| Completed |
NCT02837354 -
The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage?
|
N/A | |
| Recruiting |
NCT01361763 -
Safety Study of Dabigatran in CADASIL
|
Phase 2 | |
| Completed |
NCT06072118 -
Adrenomedullin for CADASIL
|
Phase 2 | |
| Active, not recruiting |
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
||
| Recruiting |
NCT05473637 -
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
|
||
| Enrolling by invitation |
NCT02032225 -
Generation of a Cellular Model of CADASIL From Skin Fibroblasts
|
N/A | |
| Recruiting |
NCT03047369 -
The Myelin Disorders Biorepository Project
|
||
| Active, not recruiting |
NCT04658823 -
Efficacy and Safety of Tocotrienols in CADASIL
|
Phase 2 | |
| Withdrawn |
NCT04334408 -
Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
|
Phase 2 | |
| Recruiting |
NCT05734378 -
Prognosis of Cerebral Small Vessel Disease
|
||
| Recruiting |
NCT05491980 -
Florida Cerebrovascular Disease Biorepository and Genomics Center
|
||
| Recruiting |
NCT04036084 -
Development of New Biomarkers With Magnetic Resonance Imaging for Longitudinal Studies in CADASIL Angiopathy
|
||
| Completed |
NCT01865604 -
Impact of tDCS on Cerebral Autoregulation
|
N/A |